SCHEMBL5575277

SCHEMBL5575277

NC(CNC1CCCC1)c1cccc(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ADRB3 P13945 2/20 0.42
OPRM1 P35372 5/20 0.42
OPRD1 P41143 5/20 0.42
OPRK1 P41145 5/20 0.42
OPRL1 P41146 5/20 0.42
EPHX2 P34913 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
MAPT P10636 2/20 0.40
LMNA P02545 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5573889 0.99 KDM4E (0.45) GLAHTTNPSR1KDM4EADRB3
SCHEMBL5575368 0.87 OPRM1 (0.39) ADRB3OPRM1OPRD1OPRK1OPRL1
SCHEMBL9350980 0.80 KDM4E (0.59) KDM4EL3MBTL1LMNAMEN1KMT2A
SCHEMBL5575374 0.80 KDM4E (0.59) KDM4EL3MBTL1LMNAMEN1KMT2A
SCHEMBL21539590 0.77 POLB (0.45) OPRM1OPRD1OPRK1OPRL1EPHX2
SCHEMBL18298572 0.77 POLB (0.45) OPRM1OPRD1OPRK1OPRL1EPHX2
SCHEMBL30747365 0.76 OPRL1 (0.56) OPRM1OPRD1OPRK1OPRL1SLC6A2
SCHEMBL26648907 0.76 OPRL1 (0.56) OPRM1OPRD1OPRK1OPRL1SLC6A2
SCHEMBL26649365 0.76 OPRL1 (0.56) OPRM1OPRD1OPRK1OPRL1SLC6A2
SCHEMBL5848565 0.76 ADRB2 (0.57) KDM4EADRB3ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070066624-A1 Chemokine receptor binding compounds ANORMED, INC. (CA) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066624-A1 Chemokine receptor binding compounds CCR5, CCR4, CCR1 GLA 4694/4885HTT 4524/4885NPSR1 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.